2014
DOI: 10.1183/09059180.00007813
|View full text |Cite
|
Sign up to set email alerts
|

Depression and anxiety in patients with COPD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

13
224
3
13

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 332 publications
(275 citation statements)
references
References 25 publications
13
224
3
13
Order By: Relevance
“…It is estimated that as many as 40% of patients with COPD have comorbid depression or suffer from depressive symptoms (29,30), and we found a comparable prevalence in our population. However, the percentages in our study and in the general COPD population likely underestimate the actual prevalence of depression, partly because COPD and depression share a number of overlapping symptoms such as decreased energy and fatigue (31), and the effect of COPD …”
Section: Discussionmentioning
confidence: 89%
“…It is estimated that as many as 40% of patients with COPD have comorbid depression or suffer from depressive symptoms (29,30), and we found a comparable prevalence in our population. However, the percentages in our study and in the general COPD population likely underestimate the actual prevalence of depression, partly because COPD and depression share a number of overlapping symptoms such as decreased energy and fatigue (31), and the effect of COPD …”
Section: Discussionmentioning
confidence: 89%
“…Moreover, some uncontrolled factors could have influenced the level of anxiety in our study. Indeed, anxiety symptoms were associated with sleep disturbances in the elderly 51 and with mood, 52 which could have presented day-to-day variations in our subjects.…”
Section: Discussionmentioning
confidence: 99%
“…Meanwhile, in view of complex disease pathophysiology, it has been shown that there are various potential factors that could affect the physical activity and/or quality of life in patients with COPD. These factors include skeletal muscle abnormalities (24), concomitant depression/anxiety (25,26), other co-morbidities and/or exacerbations (27). In our study significant correlations (P<0.05) were found between six-minute walk distance and total SGRQ-score (r=−0.50) and its components including symptoms, activity and impacts (r=−0.36, −0.52 and −0.43 respectively).…”
Section: Discussionmentioning
confidence: 99%